AI isn’t replacing doctors: It’s making them better. Find out why Microsoft's Dr. James Weinstein believes AI can empower both patients and physicians, while shaping a new era of smarter, more efficient care.
Firefighters sprint into dangerous situations to protect their communities. But what happens when the very act of helping others puts their own lives at risk?
Dr. Erin Kobetz and Dr. Alberto Caban-Martinez - leaders of the Firefighter Cancer Initiative at Sylvester Comprehensive Cancer Center - pull back the curtain on a health crisis: the elevated cancer risk firefighters face because of toxic exposures on the job.
Neurologist Dr. Ihtsham ul Haq reveals how cutting-edge technology is reshaping diagnosis and why stem cell therapies may hold the power to slow, or even reverse, the disease. Discover the breakthroughs, the setbacks and the race to change the future of Parkinson’s.
Autoimmune diseases like lupus and Type 1 diabetes are notoriously difficult to treat, but what if we could reprogram the immune system instead of turning it off entirely?
Preeminent immunologist Dr. Thomas Malek dives into the science behind a lab-designed fusion protein that could offer a powerful new path to long-term remission.
In this critical moment for academic medicine and scientific discovery, how can we rebuild trust in our institutions and our work? Dr. Elena Fuentes-Afflick, chief scientific officer of the Association of American Medical Colleges (AAMC) and a leading voice in support of research, joined us to tackle challenging questions and provide insight for scientists at all stages of their academic career.
Humans share 99% of their genes but, according to JacobMcCauley, Ph.D., “that one percent can tell us a lot.” The “1%” in genetic studies refers to the miniscule fraction of DNA that differentiates any two individuals but may be the key for understanding disease susceptibility.
This small variation is leading to significant discoveries.
Step into the mind of one of neurosurgery’s most influentialvoices: Michael Wang, M.D., M.B.A., a globally recognized spine surgeon and leader of the largest spine fellowship program in the country.
Dr. Wang and Dean Henri Ford tackle some of the most pressing challenges for spine surgeons: society scrutiny, public perception, patient trust, work-life balance, spiritual weight of the job and more. And for future and current doctors, it’s a conversation worth hearing.
Microplastics and their synthetic byproducts pose a majorrisk to humans through inhalation and ingestion. Could these microscopic pollutants play a role in infertility or cancer? Dr. Raveen Syan and her team are determined to find out.
Dr. Raveen Syan, assistant professor of clinical urology at the Desai Sethi Urology Institute, and Christina Yarborough, a medical student, joined the podcast to discuss a groundbreaking study that will examine how microplastics accumulate in female reproductive tissue and the potential health effects of these toxins.
In addition to the microplastics study, she shares insights from her research on Pelvic Floor Disorders (PFD), which impact nearly 1 in 4 women in the U.S., significantly affecting their quality of life.
Despite this prevalence, few studies have investigated the symptom burden among varying demographics and their perspectives on treatment options.
Atrial fibrillation leads to stroke, heart failure, sudden death and other health problems for millions worldwide. Yet, despite decades of research, many aspects of AFib care — from diagnosis to treatment — remain outdated.
Dr. Jeffrey Goldberger joined Inside U Miami Medicine to share how he is improving decades-old models to save lives.
“I saw two patients in the office within one month of each other. They had no risk factors. They had no hypertension. They had no significant cardiac disease. And they both had strokes,” he said.
He knew the field needed to evolve.
Prostate cancer affects more than half of males by age 80. Yet, early intervention can lead to complications that profoundly reduce quality of life. In the latest episode of “Inside U Miami Medicine,” luminaries in the field of urology mull over the complex question: Does every prostate cancer diagnosis require immediate treatment?
Dr. Ian Thompson, professor emeritus at the University of Texas Health Science Center San Antonio, has spent his career studying this conundrum. During this episode, he discusses seminal findings in large-scale trials that showed invasive treatments are associated with substantial, potentially life threatening conditions.
“What took my breath away was the rate of bladder cancer after radiation,” Dr. Thompson said. “A threefold increased risk of bladder cancer…”
Dr. Dipen Parekh, founding director of the Desai Sethi Urology Institute and chief operating officer for UHealth–University of Miami Health System, also joins the conversation.
The field of radiology is in flux, shifting with wave after wave of advanced technology. While the public speculated whether artificial intelligence (AI) might render radiologists obsolete, the experts were already harnessing its power to optimize workflows, alleviate burnout, improve patient care, and redefine their role within the health care team.
At the forefront of this transformation is Dr. Alexander McKinney, Shapiro professor and chair of the Department of Radiology at the University of Miami Miller School of Medicine. He joined us to share his excitement about the incredible potential of AI in radiology.
The world of migraine is complex and often misunderstood, even though it’s one the most disabling neurologic disorders in the world. Despite its prevalence, this common disease remains deeply stigmatized.
Teshamae Monteith, M.D., a nationally recognized headache expert, sheds light on groundbreaking research, pharmaceutical innovations and emerging treatments that aim to reshape the way we think about and treat migraine.
Prostate cancer is the 2nd most common cause of cancer death in U.S. men. While initial treatments offer hope, many patients find that their cancer returns with often fatal outcomes. But what if the key to stopping this deadly progression lies in our genes?
Dr. Nima Sharifi, scientific director of the Desai Sethi Urology Institute, discovered a specific genetic variant that enables tumors to bypass treatments, effectively producing their own hormones to fuel cancer growth.
Tune in!
Dr. David Davis, is breaking new ground in understanding how toxins, especially microplastics, may contribute to neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's.
In this episode of Inside U Miami Medicine, Dr. Davis shares his journey and the groundbreaking methodologies he developed to detect and study these toxins. From cyanobacterial blooms to airborne plastic particles, he reveals the urgent need to address these environmental threats.
We’re exploring visionary breakthroughs in the field of ophthalmology with Eduardo Alfonso, M.D., director of Bascom Palmer Eye Institute. Dr. Alfonso has his sight set on an ambitious project - whole eye transplant. He and his team are currently exploring the use of an ECMO device to preserve a donated eye, enabling them to apply gene therapy and stem cells, replace specific parts of the organ, and enhance its functionality.
Tune in to hear more about this fascinating venture, as well as other breakthroughs and challenges in the field that are providing new avenues for disease modeling, drug screening and cellular therapies.
Dr. Helen Bermudez, a gastroenterology fellow, overcame immense challenges to pursue her dream. Born in Cuba, she immigrated to the U.S. at age 15. She spoke no English but carried an unwavering dedication to help others through medicine. Tune in as we explore Dr. Bermudez’s story of resilience and the advice she offers others facing similar paths.
Dr. Ashish Shah, a neurosurgeon and brain cancer researcher at Sylvester Comprehensive Cancer Center, is weaponizing viruses to make brain cancer cells more susceptible to chemotherapy and radiation. It’s a delicate process that involves delivering viral-based gene therapy directly into the tumor or tumor cavity to alter the fundamental genome of the cancer cells.
Tune in to learn how this treatment is offering new hope for glioblastoma patients.
When the very treatment keeping a patient alive also exacts a heavy toll on lives, researchers are compelled to ask, “Is there another way?”
Glioblastoma is a brutal brain cancer. It is aggressive, common and nearly always fatal. Standard treatments of radiation and chemotherapy often leave patients with cognitive problems and a diminished quality of life.
But Dr. Macarena de la Fuente, chief of the Neuro oncology Division at Sylvester Comprehensive Cancer Center, envisions a future that empowers patients to manage tumors with fewer compromises. She investigates new drugs that prolong progression-free survival and delay the need for toxic treatments.
In some of the clinical trials she and her team are advancing, the tumors even shrank in size.
In the vast landscape of medical research, few areas are as intricate and nuanced as traumatic brain injury. However, amidst these profound challenges lies the relentless pursuit of understanding and innovation spearheaded by pioneers like Dr. Dalton Dietrich.
Dr. Dietrich, scientific director of the Miami Project to Cure Paralysis, recently joined the Inside U Miami Medicine podcast to share the latest neuroscience discoveries and how novel therapies – like targeted hypothermia – may protect and enhance recovery of neurological function. He also addresses the question on many people's minds: "Does TBI lead to dementia?"
Tune in.
When disaster occurs, Dr. Elizabeth Greig runs toward the chaos. She and her team follow in the wake of hurricanes, earthquakes and other hazardous events to help the world’s most vulnerable communities heal and rebuild. They provide medical care and essential resources, bolster infrastructure and strengthen the health sector. Sometimes, they construct buildings. As of April 2024, a hospital they helped erect in Port-au-Prince, Haiti, is still functioning despite the current gang violence.
Tune in to hear her talk all things disaster response, crisis management, resilience, climate change and so much more.